Flow cytometric analysis revealed an increase in the CD80/CD86 dendritic cell ratio and the appearance of toxic T cells (CD8) and helper T cells (CD4) in the tumor tissue, indicating the ability of the ruthenium complex to activate the adaptive immune response. Here, CD8A is linked to neoplasm.